RavenQuest BioMed Inc.
RVVQF
$0.00
$0.000.00%
| 07/31/2019 | 04/30/2019 | 01/31/2019 | 10/31/2018 | 07/31/2018 | |
|---|---|---|---|---|---|
| Net Income | -199.70% | -307.13% | -634.13% | -794.73% | -2,255.57% |
| Total Depreciation and Amortization | 8,913.41% | 55,241.86% | 168,375.00% | 721,850.00% | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 331.26% | 425.98% | 511.64% | 666.37% | 3,733.33% |
| Change in Net Operating Assets | 178.00% | 170.72% | 140.91% | -15.98% | -3,121.70% |
| Cash from Operations | 93.22% | 22.28% | -198.75% | -331.29% | -20,078.92% |
| Capital Expenditure | 21.18% | -232.45% | -4,515.08% | -1,183,275.00% | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 96.10% | 96.10% | -2,273.14% | -10,027.91% | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 69.32% | 36.67% | -2,954.10% | -17,424.27% | -- |
| Total Debt Issued | -95.73% | -95.94% | 68,970.80% | 37,867.48% | 1,807.38% |
| Total Debt Repaid | -231.95% | -231.95% | -231.95% | -65.98% | -- |
| Issuance of Common Stock | -63.38% | -15.06% | 272.84% | 271.36% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 9.11% | 4.32% | -411.90% | -249.34% | -- |
| Cash from Financing | -79.74% | -56.11% | 508.30% | 495.28% | 5,250.25% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -174.93% | -173.60% | -150.15% | -185.50% | 23.48% |
